Squirrel Monkeys (Saimiri sciureus) Infected with the Agent of Bovine Spongiform Encephalopathy Develop Tau Pathology

Journal of Comparative Pathology

Volumn 147, Issue 1, 2012, Pages 84-93

  Piccardo, P ^a,b   Cervenak, J ^a   Yakovleva, O ^c   Gregori, L ^a   Pomeroy, K ^a   Cook, A ^d   Muhammad, F S ^d   Seuberlich, T ^e   Cervenakova, L ^c   Asher, D M ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c HOLLAND LABORATORY   (United States)

^d BIOQUAL INC   (United States)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bovine spongiform encephalopathy; Prion protein; Squirrel monkey; Tau protein

Indexed keywords

PRION PROTEIN; PROTEINASE K; TAU PROTEIN;

AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BEHAVIOR CHANGE; BOVINE SPONGIFORM ENCEPHALOPATHY; BOVINE SPONGIFORM ENCEPHALOPATHY AGENT; BRAIN; BRAIN DEGENERATION; CEREBELLUM; COGNITION; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; GLIOSIS; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; SQUIRREL MONKEY; WESTERN BLOTTING;

ANIMALS; CATTLE; CREUTZFELDT-JAKOB SYNDROME; DISEASE MODELS, ANIMAL; ENCEPHALOPATHY, BOVINE SPONGIFORM; MALE; MONKEY DISEASES; SAIMIRI; TAU PROTEINS; TAUOPATHIES;

BOVINAE; MACACA; MACACA FASCICULARIS; SAIMIRI; SAIMIRI SCIUREUS;

EID: 84861702240     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2011.09.004     Document Type: Article

References (66)

1. Aguzzi A., Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 2004, 116:313-327.
2. Aho L., Pikkarainen M., Hiltunen M., Leinonen V., Alafuzoff I. Immunohistochemical visualization of amyloid-β protein precursor and amyloid β in extra- and intracellular compartments in human brain. Journal of Alzheimer's Disease 2010, 20:1015-1028.
3. Alzualde A., Indakoetxea B., Ferrer I., Moreno F., Barandiaran M., et al. A novel PRNP Y218N mutation in Gerstmann-Sträussler-Scheinker disease with neurofibrillary degeneration. Journal of Neuropathology and Experimental Neurology 2010, 69:789-800.
4. Asher D.M., Gibbs C.J., Sulima M.P., Bacote A., Gajdusek D.C. Transmission of human spongiform encephalopathies to experimental animals: comparison of the chimpanzee and squirrel monkey. Transmissible Spongiform Encephalopathies - Impact on Animal and Human Health. Developments in Biological Standardization 1993, 9-13. Karger, Basel. F. Brown (Ed.).
5. Asuni A.A., Perry V.H., O'Connor V. Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease. Biochemical Society Transactions 2010, 38:545-551.
6. Bancher C., Brunner C., Lassmann H., Budka H., Jellinger K., et al. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Research 1989, 477:90-99.
7. Bautista M.J., Gutiérrez J., Salguero F.J., Fernández de Marco J.L., Romero-Trevejo J.L., et al. BSE infection in bovine PrP transgenic mice leads to hyperphosphorylation of tau protein. Veterinary Microbiology 2006, 115:293-301.
8. Biacabe A.G., Laplanche A.L., Ryder S., Baron T. Distinct molecular phenotypes in bovine prion diseases. European Molecular Biology Organization Reports 2004, 5:110-115.
9. Bons N., Lehmann S., Nishida N., Mestre-Frances N., Dormont D., et al. BSE infection of the small short-lived primate Microcebus murinus. Comptes Rendus Biologies 2002, 325:67-74.
10. Brown P., Gibbs C.J., Rodgers-Johnson P., Asher D.M., Sulima M.P., et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Annals of Neurology 1994, 35:513-529.
11. Casalone C., Zanusso G., Acutis P., Ferrari S., Capucci L., et al. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob Disease. Proceedings of the National Academy of Sciences of the USA 2004, 101:3065-3070.
12. Cervenakova L., Akimov S., Vasilyeva I., Yakovleva O., McKenzie C., et al. Fukuoka-1 strain of transmissible spongiform encephalopathy agents infects and propagates in culture murine bone marrow-derived mesenchymal stem cells. Transfusion 2011, 51:1755-1768.
13. Collinge J., Sidle K.C., Meads J., Ironside J., Hill A.F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996, 383:685-690.
14. Collinge J., Whitfield J., McKintosh E., Beck J., Mead L., et al. Kuru in the 21st century - an acquired human prion disease with very long incubation periods. Lancet 2006, 367:2068-2074.
15. Colucci M., Moleres F.J., Xie Z.L., Ray-Chaudhurry A., Gutti S., et al. Gerstmann-Sträussler-Scheinker: a new phenotype with 'curly' PrP deposits. Journal of Neuropathology and Experimental Neurology 2006, 65:642-651.
16. Comoy E.E., Casalone C., Lescoutra-Etchegaray N., Zanusso G., Freire S., et al. Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. Public Library of Science One 2008, 3:e3017.
17. Croes E.A., Roks G., Jansen G.H., Nijssen P.C.G., van Duin C.M. Creutzfeldt-Jakob disease 38 years after diagnostic use of human growth hormone. Journal of Neurology, Neurosurgery and Psychiatry 2002, 72:792-793.
18. European Food Safety Authority (EFSA) Panel on Biological Hazards (BIOHAZ), European Centre for Disease Prevention and Control Joint Scientific Opinion on any possible epidemiological or molecular association between TSEs in animals and humans. European Food Safety Authority Journal 2011, 9:1945-2056. Available online:, Accessed June 27, 2011. http://www.efsa.europa.eu/en/efsajournal/pub/1945.htm.
19. Fraser H., Dickinson A.G. Distribution of experimentally induced scrapie lesions in the brain. Nature 1967, 216:1310-1311.
20. Fraser H., Bruce M.E., Chree A., McConnell I., Wells G.A. Transmission of bovine spongiform encephalopathy and scrapie to mice. Journal of General Virology 1992, 73:1891-1897.
21. Foster J.D., Hope J., Fraser H. Transmission of bovine spongiform encephalopathy to sheep and goats. Veterinary Record 1993, 133:339-341.
22. Furuoka H., Horiuchi M., Yamakawa Y., Sata T. Predominant involvement of the cerebellum in guinea pigs infected with bovine spongiform encephalopathy (BSE). Journal of Comparative Pathology 2010, 144:269-276.
23. Ghetti B., Piccardo P., Frangione B., Bugiani O., Giaccone G., et al. Prion protein amyloidosis. Brain Pathology 1996, 6:127-145.
24. Ghetti B., Piccardo P., Spillantini M.G., Ichimyia Y., Porro M., et al. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proceedings of the National Academy of Sciences of the USA 1996, 93:744-748.
25. Ghetti B., Tagliavini F., Kovacs G., Piccardo P. Gerstmann-Sträussler-Scheinker. Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders 2011, 364-377. Wiley-Blackwell, Oxford, UK. 2nd Edit. D.W. Dickson, R.O. Weller (Eds.).
26. Giaccone G., Mangieri M., Capobianco R., Limido L., Hauw J.J., et al. Tauopathy in human and experimental variant Creutzfeldt-Jakob disease. Neurobiology of Aging 2008, 29:1864-1873.
27. Goodall C.A., Head M.W., Everington D., Ironside J.W., Knight R.S.G., et al. Raised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications. Journal of Neurology, Neurosurgery and Psychiatry 2006, 77:89-91.
28. Green A.J.E., Andrews M.M., Bishop M.T., McKenzie J.J., McCord Y., et al. Elevated phosphorylated tau pT-181 in a possible PRNP codon 129 MV vCJD case. Journal of Neurology, Neurosurgery and Psychiatry 2010, 81:1408-1409.
29. Holton J.L., Mead S., Ghandi S., Wadsworth J.D.F., Ayling H., et al. Clinico-pathological observations associated with a novel truncation mutation of PRNP. Neuropathology and Applied Neurobiology 2010, 36(Suppl. 1):2-3.
30. Ironside J.W., Ghetti B., Head M.W., Piccardo P., Will R. Prion diseases. Greenfield's Neuropathology 2008, 1197-1273. Hodder Arnold, London. 8th Edit. S. Love, D.N. Louis, D.W. Ellison (Eds.).
31. Ishizawa K., Komori T., Shimazu T., Yamamoto T., Kitamoto T., et al. Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia. Acta Neuropathologica 2002, 104:342-350.
32. Jansen C., Voet W., Head M.W., Parchi P., Yull H., et al. A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann-Sträussler-Scheinker disease phenotype: comparison with similar cases from the literature. Acta Neuropathologica 2010, 121:59-68.
33. Jayadev S., Nochlin D., Poorkaj P., Steinbart E.J., Mastrianni J.A., et al. Familial prion disease with AD-like tau pathology and clinical phenotype. Annals of Neurology 2011, 69:712-720.
34. Kascsak R. Reiterating the epitope specificity of prion specific mAb 3F4. Journal of Biological Chemistry 2010, 285:Ie5.
35. Kitamoto T., Amano N., Terao Y., Nakazato Y., Isshiki T., et al. A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis. Annals of Neurology 1993, 34:808-813.
36. Kovacs G.G., Molnár K., László L., Ströbel T., Botond G., et al. A peculiar constellation of tau pathology defines a subset of dementia in the elderly. Acta Neuropathologica 2011, 122:205-222.
37. Lasmézas C.I., Comoy E., Hawkins S., Herzog C., Mouthon F., et al. Risk of oral infection with bovine spongiform encephalopathy agent in primates. Lancet 2005, 365:781-783.
38. Lasmézas C.I., Deslys J.P., Demaimay R., Adjou K.T., Lamoury F., et al. BSE transmission to macaques. Nature 1996, 381:743-744.
39. Lasmézas C.I., Fournier J.G., Nouvel V., Boe H., Marcé D., et al. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proceedings of the National Academy of Sciences of the USA 2001, 98:4142-4147.
40. Malucci G.R., Campbell T.A., Dickinson A., Beck J., Holt M., et al. Inherited prion disease with an alanine to valine mutation at codon 117 in prion protein gene. Brain 1999, 122:1823-1837.
41. Nochlin D., Sumi S.M., Bird T.D., Snow A.D., Leventhal C.M., et al. Familial dementia with PrP positive amyloid plaques: a variant of Gerstmann-Sträussler syndrome. Neurology 1989, 39:910-918.
42. OIE (2010) Bovine spongiform encephalopathy (BSE). Geographical Distribution of Countries that reported BSE Confirmed Cases since 1989. Available online: Accessed June 27, 2011. http://www.oie.int/animal-health-in-the-world/bse-specific-data/.
43. Panegyres P.K., Toufexis K., Kakulas B.A., Cervenakova L., Brown P., et al. A new PRNP mutation (G131V) associated with Gerstmann-Sträussler-Scheinker disease. Archives of Neurology 2001, 58:1899-1902.
44. Parchi P., Capellari S., Chen S.G., Petersen P.B., Gambetti P., et al. Typing prion isoforms. Nature 1997, 386:232-233.
45. Pearson G.R., Wyatt J.M., Gruffydd-Jones T.J., Hope J., Chong A., et al. Feline spongiform encephalopathy: fibril and PrP studies. Veterinary Record 1992, 131:307-310.
46. Piccardo P., Dlouhy S.R., Lievens P.M., Young K., Bird T.D., et al. Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. Journal of Neuropathology and Experimental Neurology 1998, 57:979-988.
47. Piccardo P., Manson J.C., King D., Ghetti B., Barron R.M. Accumulation of PrP in the brain that is not associated with transmissible disease. Proceedings of the National Academy of Sciences of the USA 2007, 104:4712-4717.
48. Plinston C., Hart P., Chong A., Hunter N., Foster J., et al. Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy infection following passage in sheep. Journal of Virology 2011, 85:1174-1181.
49. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216:136-144.
50. Sc in the same brain. Neurology 1999, 53:2173-2176.
51. Race B., Meade-White K.D., Miller M.W., Barbian K.D., Rubenstein R., et al. Susceptibilities of nonhuman primates to chronic wasting disease. Emerging Infectious Diseases 2009, 15:1366-1376.
52. Reiniger L., Lukic A., Linehan J., Rudge P., Collinge J., et al. Tau, prions and Aβ: the triad of neurodegeneration. Acta Neuropathologica 2011, 121:5-20.
53. Ryder S.J., Hawkins S.A., Dawson M., Wells G.A. The neuropathology of bovine spongiform encephalopathy in the pig. Journal of Comparative Pathology 2000, 122:131-143.
54. Sepulveda-Falla D., Matschke J., Bernreuther C., Hagel C., Puig B., et al. Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer's disease. Brain Pathology 2011, 21:452-463.
55. Seuberlich T., Heim D., Zurbriggen A. Atypical transmissible spongiform encephalopathy in ruminants: a challenge for disease surveillance and control. Journal of Veterinary Diagnostic Investigation 2010, 22:823-842.
56. Sikorska B., Liberski P.P., Sobów T., Budka H., Ironside J.W. Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker disease. Neuropathology and Applied Neurobiology 2009, 35:46-59.
57. Tagliavini F., Giaccone G., Prelli F., Verga L., Porro M., et al. A68 is a component of paired helical filaments of Gerstmann-Sträussler-Scheinker disease, Indiana kindred. Brain Research 1993, 616:325-328.
58. Turner M.L., Ludlam C.A. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. British Journal of Haematology 2009, 144:14-23.
59. res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. Public Library of Science Pathogens 2008, 4:e1000029.
60. Wells G.A., Scott A.C., Johnson C.T., Gunning R.F., Hancock R.D., et al. A novel progressive spongiform encephalopathy in cattle. Veterinary Record 1987, 121:419-420.
61. Wilesmith J.W., Wells G.A. Bovine spongiform encephalopathy. Current Topics in Microbiology and Immunology 1991, 172:21-38.
62. Wilesmith J.W., Wells G.A., Cranwell M.P., Ryan J.B. Bovine spongiform encephalopathy: epidemiological studies. Veterinary Record 1988, 123:638-644.
63. Will R.G., Ironside J.W., Zeidler M., Cousens S.N., Estibeiro K., et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996, 347:921-925.
64. Williams L., Brown P., Ironside J., Gibson S., Will R., et al. Clinical, neuropathological and immunohistochemical features of sporadic and variant forms of Creutzfeldt-Jakob disease in squirrel monkey (Saimiri sciureus). Journal of General Virology 2007, 88:688-695.
65. World Health Organization WHO Guidelines on Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies 2006, Available online: http://www.who.int/bloodproducts/tse/WHO%20TSE%20Guidelines%20FINAL-22%20JuneupdatedNL.pdf. A. Padilla, D.M. Asher (Eds.).
66. Yull H.M., Ritchie D., Langeveld J.P.M., van Zijderveld F.G., Bruce M.E., et al. Detection of type 1 prion protein in variant Creutzfeld-Jakob disease. American Journal of Pathology 2006, 168:151-157.